ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-β peptide (1–40) at the blood–brain barrier
- 31 May 2008
- journal article
- research article
- Published by Elsevier BV in Neurochemistry International
- Vol. 52 (6), 956-961
- https://doi.org/10.1016/j.neuint.2007.12.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood–brain barrierNeurochemistry International, 2008
- Cerebral clearance of human amyloid‐β peptide (1–40) across the blood–brain barrier is reduced by self‐aggregation and formation of low‐density lipoprotein receptor‐related protein‐1 ligand complexesJournal of Neurochemistry, 2007
- In vivo delivery of small interfering RNA targeting brain capillary endothelial cellsBiochemical and Biophysical Research Communications, 2006
- A lipid boundary separates APP and secretases and limits amyloid β-peptide generationThe Journal of cell biology, 2004
- Brain Insulin Impairs Amyloid-β(1-40) Clearance from the BrainJournal of Neuroscience, 2004
- Raft and cytoskeleton associations of an ABC transporter: P‐glycoproteinCytometry Part A, 2004
- Human ABCA1 Contains a Large Amino-Terminal Extracellular Domain Homologous to an Epitope of Sjögren's SyndromeBiochemical and Biophysical Research Communications, 2001
- Apolipoprotein A-I Directly Interacts with Amyloid Precursor Protein and Inhibits Aβ Aggregation and ToxicityBiochemistry, 2001
- Apolipoprotein Specificity for Lipid Efflux by the Human ABCAI TransporterBiochemical and Biophysical Research Communications, 2001
- Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen geneAAPS PharmSci, 2000